Skip to main content
. 2023 Dec 21;15(1):189–199. doi: 10.1007/s41999-023-00903-w

Table 3.

Comparison of severity of incident ADRs between people with and without diabetes

Incident ADRs Total no. of incident ADRs (n = 828)
n (%)
Incident ADRs in people with diabetes (n = 334)
n (%)
Incident ADRs in people without diabetes (n = 494)
n (%)
p-value
Mild Moderate/severe Mild Moderate/severe
Acute bleeding 68 (8.2) 17 (5.1) 9 (2.7) 23 (4.7) 19 (3.8) 0.58
Acute diarrhoea 65 (7.9) 22 (6.6) 5 (1.5) 28 (5.7) 10 (2) 0.27
New onset constipation 138 (16.7) 7 (2.1) 34 (10.2) 18 (3.6) 79 (16) 0.16
Acute dyspepsia/nausea/vomiting 68 (8.2) 6 (1.8) 21 (6.3) 17 (3.4) 24 (4.9) 0.42
Acute kidney injury (AKI) 99 (11.9) 20 (6) 27 (8.1) 24 (4.9) 28 (5.7) 0.008
Symptomatic hypoglycaemia (SH) 14 (1.7) 2 (0.6) 12 (3.6) 0 0  < 0.001
New onset fall/S 22 (2.7) 6 (1.8) 4 (1.2) 9 (1.8) 3 (0.6) 0.31
Delirium 44 (5.3) 11 (3.3) 8 (2.4) 17 (3.4) 8 (1.6) 0.26
Major serum electrolyte disturbance 163 (19.7) 24 (7.2) 31 (9.3) 43 (8.7) 65 (13.2) 0.69
Symptomatic bradycardia 11 (1.3) 1 (0.3) 1 (0.3) 4 (0.8) 5 (1) 0.24
Symptomatic orthostatic hypotension 16 (1.9) 2 (0.6) 4 (1.2) 8 (1.6) 2 (0.4) 0.84
New onset unsteady gait 3 (0.4) 1 (0.3) 0 1 (0.2) 1 (0.2) 1.00
Unspecified adverse event 117 (14.1) 28 (8.4) 31 (9.3) 24 (4.9) 34 (6.9) 0.006

ADRs adverse drug reactions